Source: FOOD SAFETY NEWS, 1/5/17

A key plank in the FDA’s platform to slow down the development of antibiotic resistance and extend the life of medications important to humans is in place. The agency announced Wednesday it has completed the implementation of Guidance for Industry #213. Known in the animal pharmaceutical industry as GFI #213, the Food and Drug Administration began the process...

For more of this story, click here.